Using this prominent growth-promoting effect of the activation of the CNP/NPR-B pathway on skeletal tissues, a CNP analogue was developed to improve the impaired skeletal growth observed in patients with achondroplasia, one of the most common forms of skeletal dysplasia [31,32]. This evidence concerns the gene CNP and skeletal dysplasia.